Abrinica, Clyde .
HRN: 27-22-75 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2025
CEFTRIAXONE 1G (VIAL)
06/02/2025
06/09/2025
IV
660mg
Q24
PCAP D
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes